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Why Neuroscience Matters for Rational 
Drug Policy 
David M. Eagleman, Mark A. Correro &           
Jyotpal Singh* 
I.  INTRODUCTION 
 Drug addiction is an ancient problem for society, leading to 
crime, diminished productivity, mental illness, disease 
transmission, and a burgeoning prison population. According to 
the Bureau of Justice Statistics, nearly seven out of ten jail 
inmates met the criteria for substance abuse or dependence in 
the year before their admission.1 One study found that 35.6% of 
convicted jail inmates were under the influence at the time of 
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 1. BUREAU OF JUSTICE STATISTICS, U.S. DEP’T OF JUSTICE, SPECIAL 
REPORT: SUBSTANCE DEPENDENCE, ABUSE, AND TREATMENT OF JAIL INMATES 
1 (2002), available at http://www.ojp.usdoj.gov/bjs/pub/pdf/sdatji02.pdf 
[hereinafter SUBSTANCE DEPENDENCE] (“In 2002, 68% of jail inmates reported 
symptoms in the year before their admission to jail that met substance 
dependence or abuse criteria.”). 
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their criminal offense.2 The cost to society of drug abuse has 
been estimated at $180.9 billion, of which $107.8 billion is 
derived from drug-related crime.3 The linkage between drug 
abuse and crime has been thoroughly established elsewhere. 
Promising new developments relating to emerging knowledge 
and technologies may provide a bridge between the failed 
policies of the past and novel solutions in the future. Drug 
addiction is rooted in the biology of the brain, and society’s best 
hope for breaking addiction lies in new ideas for rehabilitation, 
not in repeated incarceration. 
 The past two decades have witnessed remarkable 
progress in understanding the neural basis of drug addiction.4 
Chronic drug use leads to enduring physical changes in the 
structure of the brain, and these are thought to undermine 
what we understand as voluntary control.5 Drug addiction 
manifests itself as an irrepressible drive to take a drug despite 
its undesirable consequences.6 For decades it was thought that 
drug addiction resulted from physical dependence on the drug; 
because withdrawal symptoms could be serious, even life-
threatening, drug addiction was thought to be the same as 
physical dependence. By contrast, a new way of thinking 
suggests that drug addiction is more than dependence; it is the 
result of a reconfiguration of the circuitry of the reward and 
                                                          
 2. BUREAU OF JUSTICE STATISTICS, U.S. DEP’T OF JUSTICE, SPECIAL 
REPORT: DRUG USE, TESTING, AND TREATMENT IN JAILS 1 (2000), available at 
http://www.ojp.usdoj.gov/bjs/pub/pdf/duttj.pdf (showing that, in 1998, 35.6% of 
convicted jail inmates, or 138,000 individuals, were under the influence at the 
time of offense). 
 3. NAT’L INST. ON DRUG ABUSE, NAT’L INSTS. OF HEALTH, PRINCIPLES OF 
DRUG ABUSE TREATMENT FOR CRIMINAL JUSTICE POPULATIONS: A RESEARCH 
BASED GUIDE 26 (2006), available at 
http://www.drugabuse.gov/PDF/PODAT_CJ/PODAT_CJ.pdf (“In 2002, it was 
estimated that the cost to society of drug abuse was $180.9 billion . . . a 
substantial portion of which—$107.8 billion—is associated with drug-related 
crime, including criminal justice system costs and costs borne by victims of 
crime.”). 
 4. E.g., Alan I. Leshner, Addiction Is a Brain Disease, and It Matters, 
278 SCI. 45, 45 (1997) (“Dramatic advances over the past two decades in both 
the neurosciences and the behavioral sciences have revolutionized our 
understanding of drug abuse and addiction.”). 
 5. Nora D. Volkow & Ting-Kai Li, Drug Addiction: The Neurobiology of 
Behaviour Gone Awry, 5 NATURE REVS. NEUROSCI. 963, 963 (2004) (“[R]ecent 
studies have shown that repeated drug use leads to long-lasting changes in the 
brain that undermine voluntary control.”). 
 6. Id. 
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decision-making systems, leading to increased cravings and 
diminished impulse control. In other words, addiction may be 
reasonably viewed as a neurological problem that allows for 
medical remedies, just as pneumonia may be viewed as an 
affliction of the lungs that allows for the same. As we progress 
in our understanding of the underlying circuitry of addiction, 
how that circuitry leads to drives, and how drugs hijack and 
reregulate that circuitry, we have the opportunity to leverage 
that understanding into more effective drug policy that rests on 
treatment rather than punishment. 
 Part II briefly reviews the extent of the drug addiction 
problem in the United States and describes where American 
drug policy has fallen short in its attempts to move from 
punishment toward rehabilitation. Part III reviews the modern 
neuroscientific understanding of reward and addiction, building 
the argument that treating addiction requires an 
understanding of the neural mechanisms involved in reward 
systems, craving, and impulse control. Given the growing 
biological understanding of addiction, we argue that science 
must play a critical role in reforming drug policy. Part IV 
explores cutting-edge ideas that offer new hope for treating 
addiction directly rather than resorting to repeated rounds of 
incarceration. Here, we describe two innovative strategies—
cocaine vaccines and real-time feedback in neuroimaging—
which offer fresh approaches to rehabilitation and new 
opportunities for dialogue regarding the problem of drug 
addiction. 
II.  WHAT TO DO ABOUT DRUG ADDICTS? 
A.  HISTORICAL TENSIONS BETWEEN PUNISHMENT AND 
REHABILITATION 
 For centuries, societies have grappled with complex 
ethical questions about how to deal with drug addicts. In 
Robinson v. California, Justice Douglas wrote that an approach 
of moral condemnation “continues as respects drug 
addicts . . . . [T]hose living in a world of black and white put the 
addict in the category of those who could, if they would, forsake 
their evil ways.”7 Rather than looking at drug addiction as a 
                                                          
 7. Robinson v. California, 370 U.S. 660, 669–70 (1962) (Douglas, J., 
concurring). 
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scientific and medical phenomenon, many continue to cast the 
issue in moral terms. It is perhaps not surprising that the 
criminal justice system has generally used retributive justice to 
deal with addicts, much like it once did for the mentally ill.8 
The retributive stance generally extols “just deserts” and 
diminishes rehabilitative attempts, even those guided firmly by 
physiological understandings of the underlying pathologies. 
Nevertheless, rehabilitative efforts have made meaningful 
appearances throughout the twentieth century. 
 In the twentieth century, American drug policy 
vacillated between punishment and rehabilitation. For 
example, in the mid-twentieth century, attempts to treat and 
rehabilitate addicts, rather than simply incarcerate them, 
dominated social policy.9 These developments were facilitated 
by advances in psychology and psychiatry.10 At that time, even 
the Supreme Court seemed to embrace rehabilitation rather 
than retribution. 
 In 1962, the Supreme Court found unconstitutional a 
California statute that made addiction a crime.11 The statute 
stated that “[n]o person shall . . . be addicted to the use of 
narcotics . . . .”12 Rather than criminalizing conduct, the 
California statute mandated a minimum ninety day jail 
sentence based on a person’s status as an addict.13 In striking 
down the statute, the Court reasoned that addiction is a 
physiological condition requiring treatment rather than 
                                                          
 8. Id. at 668 (citing ALBERT DEUTSCH, THE MENTALLY ILL IN AMERICA: A 
HISTORY OF THEIR CARE AND TREATMENT FROM COLONIAL TIMES 13 (Holley 
Press 2008) (1937)). 
 9. Douglas Dennis, Foreword: A Consumer’s Report, 14 ST. LOUIS U. PUB. 
L. REV. 1, 4 (1994) (“Following World War II reformers made their greatest 
gains since the late 1800s . . . . ‘Rehabilitation,’ based on the ‘medical model,’ 
achieved penal prominence and credibility. Criminals could be ‘cured’ of the 
‘disease’ of criminality, so the theory went, and returned ‘rehabilitated’ to 
society.”). 
 10. Id. (“Sociologists, psychologists, and psychiatrists found fertile fields 
behind bars in which to test experimental behavior-modification programs.”). 
 11. Robinson, 370 U.S. at 667 (“[A] state law which imprisons a person 
thus afflicted as a criminal, even though he has never touched any narcotic 
drug within the State or been guilty of any irregular behavior there, inflicts a 
cruel and unusual punishment in violation of the Fourteenth Amendment.”). 
 12. Id. at 660 n.1. 
 13. Id. (“Any person convicted of violating any provision of this 
section . . . shall be sentenced to serve a term of not less than 90 days nor more 
than one year in the county jail.”). 
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punishment.14 
 By the late 1960s, however, the failure of science to find 
biological solutions for addiction led to increased skepticism 
about rehabilitation in the Supreme Court. In 1968, the Court 
rejected Leroy Powell’s argument that alcoholism excused him 
from being drunk in public.15 Powell argued that his public 
intoxication was not volitional and, therefore, punishing him 
for it was cruel and unusual.16 The psychiatrist who testified in 
the case acknowledged that there was no medical consensus 
over a definition of alcoholism or whether alcoholism was a 
disease; however, he asserted that the defendant, as a “chronic 
alcoholic” was “not able to control his behavior.”17 But the 
Court found his argument a stretch because it went “much too 
far on the basis of too little knowledge.”18 At that time, there 
existed a lack of effective treatment options and consensus 
regarding treatment efficacy.19 Moreover, treatment facilities 
and trained providers were scarce.20 Finally, without adequate 
treatment and facilities, a civilly committed addict could be 
held indefinitely without being criminally confined due to the 
fact that he had virtually no chance of being successfully 
rehabilitated.21 Finding no viable treatment alternatives, the 
Court concluded that criminal process was still necessary.22 
                                                          
 14. Id. at 667. 
 15. Powell v. Texas, 392 U.S. 514, 531–37 (1968). 
 16. Id. at 517. 
 17. Id. at 517–18. 
 18. Id. at 521. 
 19. Id. at 527. The Court noted: 
There is as yet no known generally effective method for treating the 
vast number of alcoholics in our society. Some individual alcoholics 
have responded to particular forms of therapy with remissions of 
their symptomatic dependence upon the drug. But just as there is no 
agreement among doctors and social workers with respect to the 
causes of alcoholism, there is no consensus as to why particular 
treatments have been effective in particular cases and there is no 
generally agreed-upon approach to the problem of treatment on a 
large scale. 
Id. 
 20. Id. at 528–29. 
 21. Id. at 529. 
 22. Id. at 530. Explaining its reasoning further, the Court went on to 
state: 
 Faced with this unpleasant reality, we are unable to assert that the 
use of the criminal process as a means of dealing with the public 
aspects of problem drinking can never be defended as rational . . . . If, 
in addition to the absence of a coherent approach to the problem of 
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 The 1970s heralded the “era of harsh prison sentences.”23 
Between 1972 and 2000, the incarcerated population grew to 
more than two million.24 According to recent studies, the “sharp 
rise in incarceration for drug-related offenses” directly fueled 
this increase.25 This trend was further driven by societal 
problems in the 1980s, the crack cocaine epidemic began,26 and 
with it came the “War on Drugs.”27 The role of crack was 
implicated by researchers in the rise of violence and crime,28 
leading to calls for longer prison sentences and cleaning up of 
the streets. 
 By the 1990s, the trend began to shift back toward 
rehabilitation. In 1990, President George H.W. Bush and 
Congress officially designated the 1990s as the “Decade of the 
Brain.”29 In parallel with the acceptance and developments of 
neuroscience, the shift from a retributive criminal policy 
toward a more rehabilitative stance has continued. Recent 
government30 and American Bar Association31 data bear out 
                                                          
treatment, we consider the almost complete absence of facilities and 
manpower for the implementation of a rehabilitation program, it is 
difficult to say in the present context that the criminal process is 
utterly lacking in social value. 
Id. 
 23. Stephen A. Saltzburg & James R. Thompson, 2007 A.B.A. SEC. CRIM. 
L. REP. 2, available at 
http://meetings.abanet.org/webupload/commupload/CR209800/newsletterpubs/
ReportI.PDF.121306.pdf. 
 24. E.g., Steven D. Levitt, Understanding Why Crime Fell in the 1990s: 
Four Factors that Explain the Decline and Six that Do Not, J. ECON. PERSP., 
Winter 2004, at 163, 177. 
 25. Id. 
 26. Id. at 179. 
 27. E.g., Saltzburg & Thompson, supra note 23, at 2. 
 28. E.g., Levitt, supra note 24, at 179–80. 
 29. E.g., Edward G. Jones & Lorne M. Mendell, Assessing the Decade of 
the Brain, 284 SCI. 739, 739 (1999). 
 30. See SUBSTANCE DEPENDENCE, supra note 1, at 8. The report indicates 
that, in 2002, 47% of addict inmates participated in treatment or other 
programs while under correctional supervision. Trends indicate that these 
numbers are growing. 
 31. See Saltzburg & Thompson, supra note 23, at 4–8. The 
recommendations urge governments to move away from pure incarceration 
methods of punishment toward community supervision, deferred adjudication, 
mental health treatment, and substance abuse treatment when the offender is 
not a threat to the community, has not committed a predatory or other serious 
crime, and lacks prior criminal history. The report explicitly acknowledges 
lingering doubts about rehabilitation but attempts to assuage these doubts 
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this trend, with examples coming from jurisdictions across the 
United States. The American Bar Association’s 2007 
recommendations demonstrate this shift. Currently, programs 
across the nation are shifting from retribution to 
rehabilitation.32 Promising changes such as the increased use 
of drug courts,33 civil commitments, community-supervised 
treatment programs, and other rehabilitative strategies are 
beginning to supplant the old focus on incarceration. 
Neuroscience is critical to this new wave of treatment and 
rehabilitation. 
 Now, at the dawn of the twenty-first century, the 
decades-long demand for punishment is straining the criminal 
justice system. Recidivism rates are high. In fact, “more than 
two-thirds of those being released from prison [are] rearrested 
within three years of release, and 42% of parolees [are] 
returning to prison or jail within 24 months of their 
release . . . .”34 This prison exodus means that 650,000 
prisoners are temporarily returning to their communities every 
year. Do addicts benefit from their incarceration? If not, can we 
do more to enhance treatment outcomes and potentially reduce 
the future societal costs? Rather than cataloging addiction’s 
cost to society, new neuroscientific developments illuminate 
knowledge and technologies that provide a bridge between the 
                                                          
with evidence about the inefficacy of long prison sentences. Further, the report 
emphasizes that cost-effective strategies will depend upon a balancing of 
interests between protecting the public through incarceration and preventing 
recidivism through rehabilitation. 
 32. Beginning in 1993 in Arkansas, community-based substance abuse 
treatment, drug courts, and other measures have been combined under a 
system that allows for dismissal of charges and expungement of records. This 
program has seen significant drops in recidivism rates. In Connecticut, every 
court now has access to substance abuse evaluations and outpatient treatment 
programs, and the state has inpatient treatment programs for substance 
abusers. These strategies have also shown reduced recidivism rates. In Kings 
County, New York, repeat drug offenders facing prison time have access to 
treatment programming. The Multnomah County, Oregon STOP program 
provides certain drug offenders with the option to complete a treatment 
program to avoid prosecution. In Kansas, a new program for non-violent drug 
offenders provides a long-term treatment program. Particularly promising is 
the program’s recognition that relapse is not necessarily a failure to recover. 
Id. at 9–13. 
 33. E.g., Harris County District Courts Success Through Addiction 
Recovery, http://www.justex.net/courts/drug/adult/default.aspx (last visited 
Feb. 5, 2010). 
 34. Saltzburg & Thompson, supra note 23, at 3. 
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doctrinal literature about criminal punishment and new 
treatment solutions for the future. 
B.  SCIENTIFIC EXPLANATIONS OF BEHAVIOR 
 Many people share a concern about incorporating 
scientific explanations for behavioral problems into the law, 
and this may stem in part from historical misuse. As Zedi and 
Goodenough state: 
Incorporating biology into legal doctrine is . . . problematic. To the 
extent that biological approaches had been included in the great 
arguments of the twentieth century between fascism, communism, 
capitalism, socialism, dictatorship and liberal democracy, they often 
wore a distorted and appropriately discredited aspect that had more 
to do with political expediency than with any accurate application of 
the admittedly limited science of the times.35 
Considering recent history, apprehension to the use of 
science in making social policy is justified. “But that biology 
should have been thus misused in the past is not a good reason 
for not taking account of its findings in the future, always of 
course with appropriate safeguards.”36 
A second concern, also shared by many, is that a 
neuroscientific understanding may exculpate criminals, 
allowing them to “blame their brains” for their behavior. Most 
people believe that there is some sense in which criminals 
should be held responsible for their actions, irrespective of the 
states of their brains, and therefore the idea of exculpation is 
unpalatably. We suggest that this belief does not need to be a 
concern. Societies will continue to remove dangerous people 
from the streets. Explanation does not equal exculpation; 
instead it can equal rational sentencing and customized 
rehabilitation. Rehabilitative treatments remove the threat 
addicts pose to innocent people and save society the associated 
costs that would be incurred were the addicts incarcerated. In 
this respect, a consequentialist or utilitarian approach may be 
more effective and less expensive than retribution and 
punishment. The ultimate issue, then, from a scientific 
perspective, is not how the criminal justice system can exact 
revenge for an evil act, but, instead, whether the underlying 
problem can be fixed through utilization of what is known of 
                                                          
 35. Semir Zeki & Oliver R. Goodenough, Law and the Brain: Introduction, 
359 PHIL. TRANSACTIONS ROYAL SOC’Y OF LONDON B 1661, 1661 (2004). 
 36. Id. 
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the neuroscience of addiction so that neither the addict nor the 
next victim has to suffer. 
 We suggest that the most fruitful path is to forego the 
arguments of responsibility in favor of concentrating 
neuroscientific efforts on rehabilitation. The onus is on 
neuroscience to prove that it has something to offer. If it can, 
then the legal system can act accordingly to leverage those 
assets. In this article we review the neuroscientific 
understanding of addiction and propose new treatments for 
breaking addiction and the consequent cycles of incarceration. 
In this paper we illustrate how neuroscience can back up its 
claims of addiction as a biological problem and bring actionable 
solutions to the table. 
III.  NEUROSCIENCE AND ADDICTION 
A.  BIOLOGICAL UNDERPINNINGS 
The human brain consists of hundreds of billions of cells 
called neurons, and over a trillion cells called glia. The number 
of connections between these cells amounts to between 60–240 
trillion.37 The complex pattern of connectivity in the brain—its 
‘circuitry’—is dynamic: connections between cells are 
constantly blossoming, dying, and reconfiguring.38 The pattern 
of connectivity in the brain determines behaviors, thoughts, 
and capacities, and damage to the circuitry impairs these 
functions.39 
Although addiction may involve volitional choices early on, 
it is best understood in the chronic state as a brain disease. As 
Volkow and Li put it: “[D]rug addiction is a disease of the brain, 
and the associated abnormal behaviour is the result of 
dysfunction of brain tissue, just as cardiac insufficiency is a 
disease of the heart and abnormal blood circulation is the 
result of dysfunction of myocardial tissue.”40 The proposal that 
addiction is biologically rooted is not new; however, modern 
                                                          
 37. GORDON M. SHEPHERD, THE SYNAPTIC ORGANIZATION OF THE BRAIN 7 
(2004); CHRISTOF KOCH, BIOPHYSICS OF COMPUTATION: INFORMATION 
PROCESSING IN SINGLE NEURONS 87 (1999). 
 38. DAVID M. EAGLEMAN, PLASTICITY: HOW THE BRAIN RECONFIGURES 
ITSELF ON THE FLY (forthcoming 2010). 
 39. DAVID M. EAGLEMAN, DETHRONEMENT: THE SECRET HEGEMONY OF 
THE UNCONSCIOUS BRAIN (forthcoming 2010). 
 40. Volkow & Li, supra note 5, at 963. 
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techniques have progressed our understanding of the neural 
basis of addiction from general ideas to specific mechanisms. In 
1968, the Supreme Court pointed out that incarceration was 
still necessary as long as a real understanding of addiction and 
useful methods of rehabilitation were lacking.41 Almost half a 
century later, we are close to meeting that challenge. 
 The brain contains circuitry that properly guides 
animals in cognitive functions such as decision-making, 
motivation, learning, and emotion.42 These circuits, largely 
involving the neurotransmitter43 dopamine (and hence referred 
to as dopaminergic) seem to be almost identical across the 
family tree of animal species44, which typically suggests deep 
evolutionary importance. These systems evolved to guide 
animals’ decisions in their pursuit of food, drink, and mates.45 
 Drugs of abuse hijack these reward and decision-making 
systems. One of the first steps in addiction is reinforcement 
from drug-induced increases in dopaminergic activity.46 In 
other words, the drug is interpreted as a highly positive 
stimulus, and the brain’s dynamic circuitry is reconfigured to 
make the brain seek more of it.47 The same mechanisms that 
normally lead to proper foraging (e.g., if you find a good food 
source, you seek more of it), are now commandeered by the 
drug. In this framework, addiction is understood as a normal 
process gone awry.48 
                                                          
 41. Powell v. Texas, 392 U.S. 514, 522–30 (1968). 
 42. See generally READ MONTAGUE, WHY CHOOSE THIS BOOK?: HOW WE 
MAKE DECISIONS 335 (2006). 
 43. A neurotransmitter is a small chemical that is secreted from one cell 
and detected by another. It is the main mode of communication between cells 
in the brain. Although several different neurotransmitter types in the human 
brain are implicated in addiction, dopamine is one of the main players. 
 44. Alison Abbot, Addicted, 419 NATURE 872, 872 (2002). 
 45. Id. 
 46. In other words, the drug causes increased levels of dopamine, and this 
causes the brain to reinforce the last behavior (i.e., the taking of the drug). 
Reinforcement is the same concept used with Pavlov’s dogs: by delivering food 
after the bell, the bell becomes a predictor of reward. 
 47. A. David Redish, Addiction as a Computational Process Gone Awry, 
306 SCIENCE 1944, 1945–46 (2004); Nora Volkow et al., Dopamine in Drug 
Abuse and Addiction: Results from Imaging Studies and Treatment 
Implications, 9 MOLECULAR PSYCHIATRY 557, 561–63 (2004); Rita Z. Goldstein 
& Nora Volkow, Drug Addiction and Its Underlying Neurobiological Basis: 
Neuroimaging Evidence for the Involvement of the Frontal Cortex, 159 AM. J. 
PSYCHIATRY 1642, 1645–46 (2002). 
 48. Redish, supra note 477, at 1944; Volkow et al., supra note 477, at 557; 
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 As a consequence of the reinforcement, the brain 
becomes physically dependent on the chemicals provided by the 
drug taking. The number of neurotransmitter receptors49 for 
the drug will often increase, which, in the homeostatic 
environment of the brain, causes ripples of change throughout 
the system—these changes include gene expression, protein 
products, and neural networks.50 This re-wiring of the brain 
often leads to dangerous consequences: when an addict stops 
taking a drug, there can be severe negative withdrawal effects. 
Anyone who has witnessed an alcoholic suffer through the 
delirium tremens (which, in the worst cases, can be fatal) can 
grasp that withdrawal symptoms are a factor in sustaining 
addiction. For many decades, scholars theorized that drug 
addiction results from an avoidance of these negative 
withdrawal effects51—i.e., once a person is physically 
dependent on a substance, withdrawal difficulties serve as the 
basis of addiction. But certain clinical facts do not fit this 
physical-dependence model of drug addiction. For example, 
addicts will often detoxify entirely, moving past the initial 
period of physical withdrawal symptoms, and then years later 
they will re-commence their compulsive drug-taking. Thus, the 
question remained why addicted brains continue to stay 
addicted. The answer seems to be two-fold: increased craving 
and diminished impulse control. 
 The first issue—craving—involves the maintenance of 
drug addiction from conditioned sensory cues. That is, stimuli 
associated with the drug (such as the location of drug-taking, 
paraphernalia associated with the drug, and so on) begin to 
drive cravings, and hence drug-seeking behavior. Under the 
positive incentive theory, addicts continue to use drugs due to 
                                                          
see David M. Egelman et al., A Computational Role for Dopamine Delivery in 
Human Decision-Making, 10 J. COGNITIVE NEUROSCI. 623, 629 (1998) 
(implicating the dopaminergic system in human decision-making). 
 49. A neurotransmitter receptor is a specialized protein molecule situated 
on the surface of cells. Chemical signals of the right shape (neurotransmitters) 
attach to the receptor, initiating a cellular response. 
 50. A system is homeostasic if it adjusts its internal environment so as to 
maintain stability. When new chemicals (e.g., drugs) are introduced into the 
brain, adjustments take place at many levels and at many time scales. Eric J. 
Nestler, Molecular Basis of Long-Term Plasticity Underlying Addiction, 2 
NATURE REVS. NEUROSCI. 119, 122, 125–26 (2001). 
 51. Terry E. Robinson & Kent C. Berridge, The Psychology and 
Neurobiology of Addiction: An Incentive-Sensitization View, 95 ADDICTION 
(SUPPLEMENT 2) S91, S92 (2000). 
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their cravings for the drug effects.52 This helps account for 
factors which a physical dependence theory alone does not. For 
example, former addicts tend to relapse more often if they find 
themselves in a familiar environment that was previously 
associated with drug use53—this suggests that it is the learned, 
anticipated pleasure that drives these actions. In fact, one can 
make predictions about the likelihood of relapse based on 
responses (both physiological and subjective craving) triggered 
by drug-related cues.54 Because of the role of conditioned drug-
related cues, craving reduction is now considered a major 
target for interventions, both psychological and 
pharmaceutical.55 As discussed in Part III below, new 
technologies may directly target the neural networks 
underlying these subjective cravings. 
 The second contributor to addictive behavior is the 
inability to control impulses.56 Normally, in the service of 
                                                          
 52. Id. at S92–S93; see also Samuel M. McClure et al., A Computational 
Substrate for Incentive Salience, 26 TRENDS IN NEUROSCI. 423, 423–24 (2003) 
(proposing that dopamine is crucial to the initiation of reward-seeking 
behavior). 
 53. NAT’L INST. ON DRUG ABUSE, supra note 3, at 19. 
 54. See Delwyn Catley et al., Absentminded Lapses During Smoking 
Cessation, 14 PSYCHOL. ADDICTIVE BEHAVIORS 73, 75–76 (2000) 
(demonstrating that relapses can occur, independent of craving, when the 
subject is in a situation consistent with previous use patterns); see also Joel D. 
Killen et al., Prospective Study of Factors Influencing the Development of 
Craving Associated with Smoking Cessation, 105 PSYCHOPHARMACOLOGY 191, 
195 (1991) (showing subjective craving to be a strong predictor of relapse); Joel 
D. Killen & Stephen P. Fortmann, Craving is Associated with Smoking 
Relapse: Findings from Three Prospective Studies, 5 EXPERIMENTAL & 
CLINICAL PSYCHOPHARMACOLOGY 137, 140–41 (1997) (exploring subjective 
craving as a predictor of relapse). 
 55. Arthur L. Brody et al., Attenuation of Cue-Induced Cigarette Craving 
and Anterior Cingulate Cortex Activation in Bupropion-Treated Smokers: A 
Preliminary Study, 130 PSYCHIATRY RES.: NEUROIMAGING 269, 277–79 (2004); 
see also Paul M. Cinciripini et al., Combined Effects of Venlafaxine, Nicotine 
Replacement, and Brief Counseling on Smoking Cessation, 13 EXPERIMENTAL 
& CLINICAL PSYCHOPHARMACOLOGY 282, 289–90 (2005) (exploring the success 
of multi-facet treatment approach in smoking cessation); Carlo C. DiClemente 
et al., Readiness and Stages of Change in Addiction Treatment, 15 AM. J. ON 
ADDICTIONS 103, 112–15 (2004) (examining the usefulness of a stages-based 
model for addiction recovery). 
 56. Steven E. Hyman, The Neurobiology of Addiction: Implications for 
Voluntary Control of Behavior, 7 AM. J. BIOETHICS 8, 9–10 (2007); see Antoine 
Bechara et al., Different Contributions of the Human Amygdala and 
Ventromedial Prefrontal Cortex to Decision-Making, 19 J. NEUROSCI. 5473, 
5479–81 (1999) (implicating the amygdala in making advantageous decisions); 
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longer-term goals, behavioral guidance signals will inhibit 
urges. But in addicts, diminished inhibition allows the 
unmasking of compulsive drug-seeking and drug-taking.57 
Simple cognitive tasks that measure an individual’s capacity 
for cognitive control, such as quickly inhibiting a motor 
response, serve as strong predictors of treatment compliance 
and relapse.58 In methamphetamine addicts, brain activity 
while performing such simple tasks correlates with relapse up 
to a year after cessation.59 Again, Part III leverages this 
understanding to illustrate ways of targeting this deficit in a 
specific manner. 
B.  WHY THE SCIENCE SHOULD SHAPE THE POLICY 
 The United States has a history of combating the drug 
problem with increased law enforcement rather than 
                                                          
P.W. Kalivas et al., Unmanageable Motivation in Addiction: A Pathology in 
Prefrontal-Accumbens Glutamate Transmission, 45 NEURON 647, 649 (2005) 
(arguing that changes in brain functioning “result in the compulsive focusing 
of behavior on drug associated stimuli . . . .”); Goldstein & Volkow, supra note 
47, at 1643 (proposing that addiction results in a loss of willed behaviors). 
 57. Dan I. Lubman et al., Addiction, A Condition of Compulsive 
Behaviour?: Neuroimaging and Neuropsychological Evidence of Inhibitory 
Dysregulation, 99 ADDICTION 1491, 1492 (2004); see also Rita Z. Goldstein et 
al., Severity of Neuropsychological Impairment in Cocaine and Alcohol 
Addiction: Association with Metabolism in the Prefrontal Cortex, 42 
NEUROPSYCHOLOGIA 1447, 1455–57 (2004) (comparing neuropsychological 
impairment of cocaine addicts and alcoholics). 
 58. In essence, such an experiment would involve pressing a button when 
cued to do so. In some trials, the participant is suddenly asked not to press the 
button. People with high impulsivity are unable to stop themselves. As an 
example of using simple cognitive tasks as outcome predictors, see W. Miles 
Cox et al., Alcohol Attentional Bias as a Predictor of Alcohol Abusers’ 
Treatment Outcome, 68 DRUG & ALCOHOL DEPENDENCE 237, 242–43 (2002) 
(demonstrating that among alcohol abusers, a relationship exists between less 
distraction from alcohol-related stimuli and successful treatment); see also 
Andrew J. Waters et al., Attentional Bias Predicts Outcome in Smoking 
Cessation, 22 HEALTH PSYCHOL. 378, 383 (2003) (showing, among cigarette 
smokers, that less distraction by tobacco-related stimuli is a predictor of 
successfully quitting smoking); Chris C. Streeter et al., Performance on the 
Stroop Predicts Treatment Compliance in Cocaine-Dependent Individuals, 33 
NEUROPSYCHOPHARMACOLOGY 827, 832 (2008) (predicting methamphetamine 
relapse with the amount of distraction caused by drug-related stimuli). 
 59. See Martin P. Paulus et al., Neural Activation Patterns of 
Methamphetamine-Dependent Subjects During Decision Making Predict 
Relapse, 62 ARCHIVES GEN. PSYCHIATRY 761, 765–66 (2005) (finding that 
brain activity while performing a simple decision-making task is correlated 
with relapse). 
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customized intervention and rehabilitation. For years, experts 
have weighed in on this topic and come to similar conclusions 
about current drug policy. One author has stated: “[D]rug 
treatment programs remain notoriously underfunded, turning 
away tens of thousands of addicts seeking help even as 
increasing billions of dollars are spent to arrest, prosecute, and 
imprison illegal drug sellers and users.”60 Another author 
approached the issue in this way: “The investment of more than 
70% of the federal [U.S.] drug control money into supply 
reduction seems misplaced . . . . Curtailing the supply of 
demanded drugs has been compared to squeezing a balloon: 
constrict it in one place and it expands somewhere else.”61 
 In light of the current science, it would appear there is a 
better strategy for combating the drug trade: instead of 
concentrating on controlling the supply, concentrate on 
controlling the demand. Below we will consider biologically-
based strategies for addressing demand—those strategies that 
are currently in use, and some that are on the horizon. The new 
frameworks remove the emphasis on punishment in favor of 
reducing craving while strengthening impulse control. 
III.  NEUROSCIENTIFIC STRATEGIES FOR 
REHABILITATION 
 Cutting-edge ideas on the horizon offer new hope for 
directly treating drug addiction rather than focusing on 
punishment. We briefly outline the evidence-based strategies 
currently in use. We then turn to two innovative strategies—
cocaine vaccines and real-time feedback in neuroimaging—
which offer fresh approaches and new opportunities for 
dialogue in the problem of drug addiction. Such neurally-based 
treatments can equip policy-makers with tools to treat 
additions with maximal efficacy and minimum cost. 
A.  PHARMACEUTICAL STRATEGIES 
 Essentially there are two classes of pharmaceutical 
intervention: those that obstruct the effects of the drug and its 
reinforcing effects, and those that try to counterbalance 
                                                          
 60. Ethan A. Nadelmann, Drug Prohibition in the United States: Costs, 
Consequences, and Alternatives, 245 SCI. 939, 942 (1989). 
 61. Murray E. Jarvik, The Drug Dilemma: Manipulating the Demand, 250 
SCI. 387, 389. (1990). 
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changes to the brain brought on by the drug use.62 In the first 
class, biological mechanisms include direct binding of the 
medication to the receptors for the drug, or medications that 
trigger negative sensations. The second class includes 
medications that work to decrease the positive incentive of the 
drug or increase the incentive of natural reinforcers. 
 For cocaine, several medications have been found to 
reduce use. Some examples include disulfiram (a medication 
with dopaminergic effects), GABA medications (tiagabine and 
topiramate), a beta-adrenergic blocker (propranolol), and a 
stimulant (modafinil).63 
 For alcoholism, medications like naltrexone are used to 
antagonize64 the normal relationship of alcohol with its 
receptors, thus interfering with reinforcement. Other 
strategies, such as disulfiram, are used to trigger aversive 
responses. 
 Heroin (and more generally, opiate) addiction is also 
being treated with naltrexone (again as an antagonist for the 
drug receptors), as well as with substitution strategies.65 Other 
medications (e.g. methadone and buprenorphine) bind to the 
opiate receptors with different kinetics, and thus reduce 
craving and incentive by blocking the effects of the high.66 In 
other words, these medications are intended to reduce craving 
without inducing intoxication or later withdrawal symptoms. 
 In general, these measures reflect a conception of the 
brain based mainly in neurotransmitter systems. Recently, 
neuroscience has begun to develop a greater understanding of 
the mechanisms at cellular and circuitry levels as well. This 
                                                          
 62. Volkow & Li, supra note 5, at 967. 
 63. Mehmet Sofuoglu & Thomas R. Kosten, Emerging Pharmacological 
Strategies in the Fight Against Cocaine Addiction, 11 EXPERT OPINION ON 
EMERGING DRUGS 91, 91–94 (2006). 
 64. Antagonism is a concept in pharmacology in which one substance (the 
antagonist) binds to the receptors that would normally be bound by a different 
substance (in this case, the molecules of the drug), thereby blocking the drug’s 
effects. See Noeline C. Latt et al., Naltrexone in Alcohol Dependence: A 
Randomised Controlled Trial of Effectiveness in a Standard Clinical Setting, 
176 MED. J. AUSTL. 530, 530–34 (2002). 
 65. Sandra D. Comer et al., Injectable, Sustained-Release Naltrexone for 
the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial, 
63 ARCHIVES GEN. PSYCHIATRY 210, 216–17 (2006). 
 66. See Eric E. Strain et al., Comparison of Buprenorphine and 
Methadone in the Treatment of Opioid Dependence, 151 AM. J. PSYCHIATRY 
1025, 1025 (1994). 
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has opened the door to new strategies, two of which are 
discussed below. 
B.  REAL-TIME FEEDBACK USING NEUROIMAGING 
 With new understandings come new opportunities for 
more precise intervention. This is illustrated here with a new 
approach to two targets: reducing craving and strengthening 
impulse control. 
 As discussed above, subjective cravings triggered by 
drug-related cues are considered main actors in clinical and 
neuroscientific accounts of drug addiction.67 Therefore, craving 
reduction—already a prime target of cognitive-behavioral, 
psychotherapeutic, and pharmaceutical approaches—is one of 
the prime objectives for new technologies. Dozens of functional 
neuroimaging studies, mostly in nicotine and cocaine-
dependent individuals, have highlighted a distributed network 
of brain regions that show increased activity in response to 
drug-related cues.68 Not coincidentally, the areas involved are 
also implicated in normal reward processing, decision making, 
and emotional responses. One area that deserves special 
attention is an area of the cortex known as the insula, which is 
involved in emotional responses. Activation of the insula is 
strongly correlated with drug craving across different classes of 
                                                          
 67. Arthur L. Brody et al., Neural Substrates of Resisting Craving During 
Cigarette Cue Exposure, 62 BIOLOGICAL PSYCHIATRY 642, 642 (2007); Marcus 
A. Gray & Hugo D. Critchley, Interoceptive Basis to Craving, 54 NEURON 183, 
183 (2007); Rajita Sinha et al., Neural Activity Associated with Stress-Induced 
Cocaine Craving: A Functional Magnetic Resonance Imaging Study, 183 
PSYCHOPHARMACOLOGY 171, 171 (2005). 
 68. The distributed network involved in cue-triggered craving includes the 
orbitofrontal cortex, dorsolateral prefrontal cortex, anterior cingulate cortex, 
striatum, and insular cortex. Arthur L. Brody et al., Brain Metabolic Changes 
During Cigarette Craving, 59 ARCHIVES GEN. PSYCHIATRY 1162, 1166–67 
(2002); F. Joseph McClernon et al., Abstinence-Induced Changes in Self-Report 
Craving Correlate with Event-Related fMRI Responses to Smoking Cues, 30 
NEUROPSYCHOPHARMACOLOGY 1940, 1942 (2005); Stephen J. Wilson et al., 
Prefrontal Responses to Drug Cues: A Neurocognitive Analysis, 7 NATURE 
NEUROSCI. 211, (2004) (proposing potential explanations for inconsistent 
results between several neuroimaging studies); Thomas R. Kosten et al., Cue-
Induced Brain Activity Changes and Relapse in Cocaine-Dependent Patients, 
31 NEUROPSYCHOPHARMACOLOGY 644, 646–647 (2006); Teresa R. Franklin, 
Limbic Activation to Cigarette Smoking Cues Independent of Nicotine 
Withdrawal: A Perfusion fMRI Study, 32 NEUROPSYCHOPHARMACOLOGY 2301, 
2305 (2007). 
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drugs.69 Interestingly, damage to the insula disrupts subjective 
urges to smoke, without changing the motivation of other 
behaviors (such as eating).7071 These data point to the 
distributed neural network involved in craving (and the insula 
in particular) as prime targets for craving-reduction. 
 As mentioned above, there is another half to drug 
addiction besides craving: deficits in impulse control.72 
Neuroimaging has revealed a related network of areas involved 
in cognitive control, involving areas known as the orbitofrontal 
cortex (OFC), anterior cingulate cortex (ACC), and dorsolateral 
prefrontal cortex (DLPFC). For example, cocaine addicts show 
abnormal OFC and ACC activity,73 as well as diminished 
DLPFC activity,74 hand-in-hand with diminished self-control 
and poor performance on tasks that require inhibition of 
impulsive responses. In chronic smokers, the brain’s reward 
systems appear to function properly, but they are not engaged 
in the normal way for the proper cognitive control signaling.75 
These data suggest direct therapeutic interventions should be 
used to enhance cognitive control in drug addicts. 
 How can we hope to directly affect specific brain 
                                                          
 69. Brody et al., supra note 67, at 1167–68 (nicotine); Gene-Jack Wang et 
al., Regional Brain Metabolic Activation During Craving Elicited by Recall of 
Previous Drug Experiences, 64 LIFE SCI. 775, 777–779 (1999) (cocaine); L.A. 
Sell et al., Neural Responses Associated with Cue Evoked Emotional States 
and Heroin in Opiate Addicts, 60 DRUG & ALCOHOL DEPENDENCE 207, 214 
(2000) (heroin); Katherine R. Bonson et al., Neural Systems and Cue-induced 
Cocaine Craving, 26 NEUROPSYCHOPHARMACOLOGY 376, 379 (2002) (cocaine). 
 70. Nasir H. Naqvi et al., Damage to the Insula Disrupts Addiction to 
Cigarette Smoking, 315 SCIENCE 531–34 (2007); Gray & Critchley, supra note 
67, at 18386. 
 71. Gray & Critchley, supra note 67, at 18386. 
 72. Hyman, supra note 56, at 9–10; see also Antoine Bechara, Decision 
Making, Impulse Control and Loss of Willpower to Resist Drugs: A 
Neurocognitive Perspective, 8 NATURE NEUROSCI. 1458, 1458 (2005); Kalivas et 
al., supra note 56, at 647; Goldstein & Volkow, supra note 47, at 1649. 
 73. Nora Volkow & Joanna Fowler, Addiction, a Disease of Compulsion 
and Drive: Involvement of the Orbitofrontal Cortex, 10 CEREBRAL CORTEX 318, 
320 (2000). 
 74. Robert Hester & Hugh Garavan, Executive Dysfunction in Cocaine 
Addiction: Evidence for Discordant Frontal, Cingulate, and Cerebellar Activity, 
24 J. NEUROSCI. 11017, 11019–20 (2004); Rita Z. Goldstein et al., The Effect of 
Practice on a Sustained Attention Task in Cocaine Abusers, 35 NEUROIMAGE 
194, 200–01 (2007). 
 75. Pearl H. Chiu et al., Smokers’ Brains Compute, but Ignore, a Fictive 
Error Signal in a Sequential Investment Task, 11 NATURE NEUROSCI. 514, 517 
(2008). 
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networks? A new technology on the horizon—real-time 
neurofeedback—suggests one possibility. Neuroimaging known 
as functional magnetic resonance imaging (fMRI) allows the 
viewing of neural activity. In a new development owing to the 
introduction of fast computation and efficient algorithms, raw 
data from the imaging can be reconstructed on-the-fly (in close 
to ‘real-time’) and visually displayed in the scanner. In this 
way, neural activity can be shown directly to an individual and 
that person can attempt to modify it. This technique is known 
as real-time fMRI, or rt-fMRI, or simply as neurofeedback.76 
 The approach is similar to the biofeedback strategies of 
previous decades, except that it allows a view inside the skull, 
giving a level of precision never before possible. This technology 
has the potential to enable a dramatically new level of 
sophisticated exploration of brain function that goes beyond 
simple measurements of correlations between stimuli and their 
associated fMRI activations. It puts the individual in the 
driver’s seat of his own neural circuitry.77 To date, this 
technology has been used to address pain and depression. 
Neuroscience is leveraging this technology for a novel approach 
to addiction. Specifically, rt-fMRI is being used to decrease 
neural activations associated with craving and increase neural 
activations associated with cognitive control. This strategy may 
allow the overcoming of habitual responses to drug-cues in 
addicts. We have begun this experimental endeavor here at 
Baylor College of Medicine with nicotine addicts.78 It may be 
almost a year before the efficacy of this approach can be 
accurately gauged, but this integration of neural substrates of 
addiction and real-time neuroimaging is highly promising. This 
technology, together with other new developments, may 
                                                          
 76. Stephen M. Laconte et al., Real-Time fMRI Using Brain-state 
Classification, 28 HUMAN BRAIN MAPPING 1033, 1034 (2007); R. Christopher 
deCharms, Reading and Controlling Human Brain Activation Using Real-
Time Functional Magnetic Resonance Imaging, 11 TRENDS COGNITIVE SCI. 
473, 474–75 (2007); Nikolaus Weiskopf et al., Physiological Self-Regulation of 
Regional Brain Activity Using Real-Time Functional Magnetic Resonance 
Imaging (fMRI): Methodology and Exemplary Data, 19 NEUROIMAGE 577, 578 
(2003). 
 77. In other words, users can view a graphical representation of the 
amount of activity in particular areas of their brain (say, as a bar that moves 
up or down), and they can work to control it. 
 78. This work is spearheaded by our colleagues Drs. Steven LaConte, 
Pearl Chiu, Brooks King-Casas, and P. Read Montague. 
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reinvigorate the discussion of possibilities for customized 
rehabilitation. 
C.  THE COCAINE VACCINE 
 Another complementary approach circumvents the 
continued reinforcement generated by the drug high. This 
possibility is a drug vaccine, an intervention that renders the 
individual unable to become high since the immune system will 
“fight” the drug before it reaches the brain.79 
 A drug vaccination is accomplished in the traditional 
biological manner of all inoculations: a foreign substance is 
injected into the blood stream, and the immune system then 
raises antibodies against the invader. In this case, the cocaine 
molecule, which is attached to a large protein molecule, is 
injected. The new antibodies come to recognize not only the 
cocaine-protein complex, but also the naked cocaine molecule. 
Now that the body has hosted an immune response, new 
injections of cocaine into the bloodstream will be surrounded by 
the body’s natural antibodies. In this way, the vaccination 
prevents—or at minimum slows down—the crossing of the 
cocaine molecules across the blood-brain barrier.80 The high is 
thus eliminated or at least attenuated.81 Currently, the cocaine 
vaccine is in clinical trials and shows early promise. 
 Dr. Tom Kosten, one of the lead developers of the 
vaccine, sees the vaccine as most useful for addicts who desire 
to stop using cocaine, but continue to be stymied by relapses. 
The strategy is simple (if yet unproven): if an individual 
vaccinates and then relapses, she will not find the expected 
high, and her craving will eventually recalibrate. In other 
words, she will lose interest. 
 If the vaccine works well, it could shift treatment from 
counseling and rehabilitation programs to a mandatory 
vaccination. There are, of course, some potential problems with 
the notion of a drug vaccine. One is that addicts inoculated 
                                                          
 79. Frank M. Orson et al., The Future of Vaccines in the Management of 
Addictive Disorders, 9 CURRENT PSYCHIATRY REPS. 381, 381–87 (2007). 
 80. The blood-brain barrier is a collection of cells that protect the brain 
from certain chemicals in the blood while passing others through. 
 81. Bridget A. Martell et al., Vaccine Pharmacotherapy for the Treatment 
of Cocaine Dependence, 58 BIOLOGICAL PSYCHIATRY 158, 162 (2005); Laurent 
Karila et al., New Treatments for Cocaine Dependence: A Focused Review, 11 
THE INT’L J. OF NEUROPSYCHOPHARMACOLOGY 425 passim (2008).  
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against cocaine may well turn to another drug for satisfaction, 
and this highlights the importance of addressing the craving 
and impulse control issues surrounding drug taking. As Robert 
Julien notes: “Just as focus cannot be solely on the drug of 
dependence and its rewarding and withdrawal 
effects . . . neither can it be only on pharmacotherapy for 
treatment . . . . [A]ddicts will have to be able to handle later 
exposure to craving-eliciting cues in the environment.”82 
Vaccines in combination with neurofeedback may well prove to 
be a fruitful combination. 
IV.  CONCLUSION 
 Drug addiction reflects abnormal operation of normal 
neural circuitry. More than physical dependence, addiction 
represents changes in the brain that lead to increased craving 
and diminished capacity for the control of impulses. Given the 
growing biological understanding of addiction, it is critical for 
scientists to play an active role in drug policy. As 
neuroscientific understanding develops, we will, to a much 
greater degree, be able to target specific behavioral, 
pharmaceutical, and neurological treatments for specific 
addictions. It is important to emphasize that biological 
explanation will not somehow become equivalent to 
exculpation. Instead, the goal of explanation is to introduce 
rational sentencing and the opportunity for customized 
rehabilitation. This approach is likely to show more utility and 
less cost than incarceration. The neuroscientific community 
should continue to develop rehabilitative strategies so that the 
legal community can take advantage of those strategies for a 
rational, customized approach to drug addiction. 
 
 
 
                                                          
 82. ROBERT M. JULIEN, A PRIMER OF DRUG ACTION 661 (10th ed. 2004). 
